Crystal Research Associates

05/29/2026

📢 NEW REPORT RELEASED: Crystal Research Associates has issued a new Executive Informational Overview on 1911 Gold Corp. (TSX-V: AUMB | OTCQX: AUMBF), a Canadian gold explorer and developer focused on restarting the True North Gold Project in Manitoba’s Rice Lake greenstone belt. The Company controls the fully permitted True North mine, mill, and tailings facility, along with a 61,647-hectare land package that includes the Ogama-Rockland Gold Deposit and several past-producing mines. This 56-page report explores 1911 Gold's business model, growth strategy, market opportunity, competitive landscape, and key risks. Download the full report below.

📄 Access the full report below or at https://www.crystalra.com/1911-gold-corporation

If you’d like to see more content like this, hit like and follow for upcoming reports.

05/26/2026

📢 NEW UPDATE RELEASED: Crystal Research Associates has published a 10-page Company Update on BacTech Environmental Corp. (CSE: BAC | OTCQB: BCCEF | FSE: 0BT1), a Canadian cleantech company that uses bioleaching (natural bacteria) to recover metals from arsenic-rich mining waste and historic tailings while reducing environmental risk, with its lead project advancing in Ecuador. | https://www.crystalra.com/blog/may-2026-update-on-bactech-environmental-corp

02/17/2026

NEW RESEARCH on Atlas Salt Inc. (TSXV:SALT | OTCQX:SALQF) - Crystal Research issued a 45-page report on Atlas Salt, advancing the Great Atlantic Salt Project to supply de-icing salt to Eastern Canada & U.S. Northeast. | https://www.crystalra.com/atlas-salt-inc

01/09/2026

NEW RESEARCH on OS Therapies Inc. (NYSE American: OSTX) - Crystal Research issued a 62-page report on OS Therapies, a clinical-stage company developing cancer immunotherapies for osteosarcoma and solid tumors. | https://www.crystalra.com/os-therapies

01/07/2026

New Research on BacTech Environmental Corp. (CSE:BAC | OTCQB:BCCEF | FSE:0BT1) - BacTech Environmental uses bioleaching to recover metals from mining waste, improving sustainability while building a profitable cleanup model for miners. | https://www.crystalra.com/bactech-environmental

11/22/2025

New Research on Kazia Therapeutics Limited (KZIA-NASDAQ) - Crystal Research Associates has issued a 60-page report on Kazia Therapeutics, focused on paxalisib for glioblastoma/CNS cancers and EVT801 for solid tumors. | https://www.crystalra.com/kazia-therapeutics

11/19/2025

New Research on Nova Minerals, Ltd. (NVA-NASDAQ)/(NVA-ASX) - Crystal Research Associates has issued a 66-page report on Nova Minerals, a gold, antimony, and critical minerals exploration and development company focused on advancing its flagship Estelle Project in Alaska, where it holds an 85% interest.

Crystal Research Associates presents a 66-page report on Nova Minerals, a gold and antimony company advancing its Estelle Project in Alaska.

11/17/2025

November 2025 Update on GeoVax Labs, Inc. (GOVX-NASDAQ) - A 17-page Quarterly Update has been published on biotechnology company GeoVax, Labs, Inc. (GOVX-NASDAQ).

A 17-page Quarterly Update has been published on biotechnology company GeoVax, Labs, Inc. (GOVX-NASDAQ).

11/10/2025

New Research on Agroz Inc. (AGRZ-NASDAQ) - Crystal Research Associates issued a 24-page Executive Summary on Agroz Inc., a Malaysia-based AgTech firm operating climate-controlled vertical farms. | https://www.crystalra.com/agroz-inc

10/30/2025

New Research on Voyageur Pharmaceuticals Ltd. (VM-TSXV / VYYRF-PINK) - Crystal Research Associates released a 40-page report on Voyageur Pharmaceuticals, a Canadian company that makes medical imaging contrast products.

Crystal Research Associates released a 40-page report on Voyageur Pharmaceuticals, a Canadian company that makes medical imaging contrast products.